You are here: Industry Insights > AMAG

News List

FDA Considers Withdrawing Makena Approval americanpharmaceuticalreview
October 10, 2020
AMAG Pharmaceuticals has received a notice from the U.S. Food and Drug Administration (FDA) that the FDA is proposing to withdraw approval of Makena® (hydroxyprogesterone caproate injection).
AMAG Pharma Makes Organization Changes contractpharma
March 05, 2020
Executive Vice President and Chief Medical Officer, Julie Krop to leave the company.
Troubled AMAG spurns activist's attempt to rework board as share price flags fiercepharma
September 26, 2019
AMAG is in the midst of launching controversial female libido drug Vyleesi after its approval in June. While the drugmaker has high hopes for the drug, analysts have posted less-than-stellar forecasts.
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women drugs
June 24, 2019
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women.
AMAG Pharmaceuticals Appoints VP contractpharma
April 17, 2019
Griffith responsible for the creation and implementation of AMAG’s medical communications and publication strategies...
Amag merges with Perosphere, adding NOAC antidote fiercebiotech
December 26, 2018
Amag Pharma has struck a merger deal with Perosphere, adding an anticoagulant reversal agent in midstage trials to its emerging hematology business.....
AMAG's Label Expansion of Lead Products Raises Share Price nasdaq
November 27, 2018
Share price of AMAG Pharmaceuticals, Inc. AMAG has increased 37.9% year to date...